Edition:
India

Orexigen Therapeutics Inc (OREX.OQ)

OREX.OQ on NASDAQ Stock Exchange Global Select Market

1.25USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
63,254
52-wk High
$4.66
52-wk Low
$0.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 18.90 -1.349
Jun '17 23.36 -2.003
Mar '17 19.15 -4.666
FY 2016 Dec '16 13.88 -1.686
Sep '16 7.00 1.302
Jun '16 7.79 -1.732
Mar '16 5.03 -1.535
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 27.50 27.50 27.50 --
Quarter Ending Jun-18 1 27.50 27.50 27.50 --
Year Ending Dec-18 2 133.25 156.50 110.00 --
Earnings (per share)
Quarter Ending Mar-18 1 -2.17 -2.17 -2.17 --
Quarter Ending Jun-18 1 -1.59 -1.59 -1.59 --
Year Ending Dec-18 2 -5.15 -3.54 -6.76 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 37.82 114.24 50.27
EPS (TTM) % 67.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Orexigen Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -10.82 -13.90 15 --
13 Week -30.41 -33.79 10 --
26 Week -22.26 -28.17 27 --
52 Week -35.62 -45.44 25 --
YTD 18.39 3.97 57 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 43.25%
# of Holders: 59
Total Shares Held: 8,168,382
3 Mo. Net Change: 1,144,504
# New Positions: 10
# Closed Positions: 8
# Increased Positions: 19
# Reduced Positions: 20
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.